Author’s Reply: Atherogenic Index of Plasma in Elderly with Acute Coronary Syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Engin

Demirel

. Letter: atherogenic index of plasma and cardiovascular mortality. Angiology. 2025;76(10):1028.

Ser Ö

Keskin

Çetinkal

, et al. Evaluation of the atherogenic index of plasma to predict all-cause mortality in elderly with acute coronary syndrome: a long-term follow-up. Angiology. 2025;76(10):1019-27.

Di Maio

Esposito

Silverio

, et al. Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention. Catheter Cardiovasc Interv. 2023;102:779-87.

Morici

Alicandro

Ferri

, et al. Residual SYNTAX score and one-year outcome in elderly patients with acute coronary syndrome. CJC Open. 2020;2:236-43.

Inan

Genc

Şimsek

, et al. Relationship between CHA₂DS₂-VASc score on admission and in-hospital major adverse cardiovascular events in patients diagnosed with ST-elevation myocardial infarction. Angiology. 2025;76(4):330-9.

Katsiki

Filippatos

Vlachopoulos

, et al. Executive summary of the Hellenic atherosclerosis society guidelines for the diagnosis and treatment of dyslipidemias – 2023. Atheroscler Plus. 2024;55:74-92.

Alboni

Fumagalli

, et al. Evidence and uncertainties in the management of atrial fibrillation in the elderly. Minerva Med. 2022;113:626-39.

Wang

Huang

Pan

Zheng

The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: a network meta-analysis of randomized clinical trials. Int J Cardiol. 2022;357:33-8.